Medicine information
Uses & overview
ST-GLIPTIN M 100/500, from Steris Healthcare, is a combination oral antidiabetic formulation containing Sitagliptin 100 mg and Metformin Hydrochloride 500 mg. These active ingredients work through complementary mechanisms to help manage blood glucose levels in adults with type 2 diabetes mellitus when this combination is considered appropriate by their treating physician. Composition Each tablet contains: Sitagliptin: 100 mg Metformin Hydrochloride: 500 mg Company Name: Steris Healthcare Key Product Features Combination of two oral antidiabetic agents. Contains Sitagliptin 100 mg and Metformin Hydrochloride 500 mg. Combines complementary mechanisms for blood glucose management. Intended for use under medical supervision as part of an individualized diabetes management plan. Uses of ST-GLIPTIN M 100/500 ST-GLIPTIN M 100/500 may be prescribed for adults with type 2 diabetes mellitus when a healthcare professional determines that both active ingredients are suitable for the patient's treatment needs. It is generally used alongside recommended dietary measures and physical activity. How ST-GLIPTIN M 100/500 Works Sitagliptin 100 mg: Sitagliptin belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It helps prolong incretin hormone activity, supporting glucose-dependent insulin secretion and helping regulate glucagon levels. Metformin Hydrochloride 500 mg: Metformin helps reduce glucose production in the liver and improves the body's sensitivity to insulin, supporting blood glucose control. Together, these ingredients help manage blood glucose through complementary mechanisms when used as prescribed. Important Safety Information ST-GLIPTIN M 100/500 is a prescription medicine and should be used only under medical supervision. Metformin may cause gastrointestinal side effects, including nausea, diarrhoea, and abdominal discomfort. Rarely, it can cause lactic acidosis, a serious medical condition. Sitagliptin has been associated with pancreatitis, hypersensitivity reactions, and other uncommon adverse effects. The risk of low blood sugar may increase when this combination is used with insulin or sulfonylureas. Inform your doctor if you have kidney or liver problems, a history of pancreatitis, or known medicine allergies. Kidney function assessment is important before and during treatment because it affects the suitability and dosing of both ingredients. Disclaimer: This content is for educational purposes only and does not replace professional medical advice or the approved prescribing information. About Steris Healthcare ST-GLIPTIN M 100/500 is a brand associated with Steris Healthcare. For verified company information, product availability, and distribution enquiries, refer to the company's official information.
